Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-20 | New | $1,999,967 | $1,999,967 | Equity Only | 06b | SEC link |
| 2022-09-20 | New | $2,500,000 | $2,500,000 | Debt Only | 06b | SEC link |
| 2021-10-07 | New | $4,500,000 | $4,500,000 | Equity Only | 06b | SEC link |
| 2021-01-13 | New | $1,200,000 | $1,200,000 | Debt Only | 06b | SEC link |
| 2017-01-05 | New | $6,105,996 | $6,105,996 | Equity Only | 06b | SEC link |
| 2014-07-11 | Amended | $5,000,010 | $2,500,005 | Equity Only | 06b | SEC link |
| 2013-07-02 | New | $2,500,005 | $2,500,005 | Equity Only | 06 | SEC link |
| 2011-09-16 | New | $250,000 | $250,000 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Perou V. Charles | Director, Executive |
| Don Hardison | Director |
| David Neil Hayes | Director, Executive |
| Myla Lai Goldman | Director |
| Arnold Levine | Director |
| Ellen Lubman | Director |
| Michael Milburn | Director, Executive |
| Charles Perou | Director |
| Prasanth Reddy | Director |
| Clay Thorp | Director |